Učitavanje...
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
COVID-19 disease increases interleukin (IL)-1β release. Anti-IL-1-treatment is effective in IL-1-mediated autoinflammatory diseases (AID). This case series presents COVID-19 in patients with IL-1-mediated and unclassified AID with immunosuppressive therapy (IT). Patient 1 is a 34-year-old woman with...
Spremljeno u:
| Izdano u: | J Clin Med |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7915607/ https://ncbi.nlm.nih.gov/pubmed/33562758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040605 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|